glp-1 approved for pediatrics Atlanta Pediatric Weight Loss: Physician-Led Care Kids & Teens FDA Approves Semaglutide for Pediatric

Consequently, these observations have sparked renewed discussions about the therapeutic potential of GIPRAs in the long-term treatment of obesity

Glucagon-like peptide 1 receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence

Important cautions: Personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2: GLP-1s are contraindicated History of pancreatitis: Discuss risks carefully with your doctor Gallbladder issues: GLP-1s may increase gallstone risk Severe gastrointestinal disease: May worsen symptoms Pregnancy plans: Not recommended if youre trying to conceive Can GLP-1 mess with hormones? GLP-1s arent hormone therapy

Kidney Protection Starts Earlier and Runs Deeper Chronic kidney disease guidance now emphasizes: Earlier initiation of SGLT2 inhibitors Consideration of simultaneous SGLT2 inhibitor and nsMRA therapy Careful potassium and eGFR monitoring Continued use of GLP-1based therapies even in advanced CKD or dialysis Kidney protection no longer waits for advanced disease

39 This strategy involves seeking FDA approval for only those uses of a drug that are no longer protected by patents, while carving out patented indications